Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huang'e refers to "Huang'e Capsules," a traditional Chinese medicine formulation studied for the treatment of benign prostatic hyperplasia (BPH) characterized by qi-deficiency, blood-stasis, and damp-heat stagnation syndromes. In a clinical study involving 605 male patients with BPH of this type, oral administration of Huang'e Capsules resulted in significant improvements in International Prostate Symptom Score (IPSS), quality of life scores, urinary flow rates, and prostate volume after 42 days of treatment. The precise herbal composition and mechanism are not detailed in the available sources; however, it is used within the framework of traditional Chinese medicine rather than as a single pharmaceutical compound[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huang'e.